EUVIMEDEUVIMED entdecken
Crossref

Super-small zwitterionic nitric oxide-donor micelles efficiently scavenge ROS and alleviate inflammation for combined ischemic stroke therapy

Ke Wang, Yuli Ao, Yiqing Xiao, Yi Wang, Xiaoping Liang, Mingxuan Zhao, Dongyu Zhang, Yinan Zhong, Hongliang Qian, Bingbing Zhao, Wei Chen

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.08.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Ke Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Micelles, Reactive Oxygen Species, Inflammation, Ischemic Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Pharmaceutical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke has severely threatened the health of human beings, attributed to blood-brain barrier (BBB) damage, excess reactive oxygen species (ROS), and inflammation effect, which trigger neuronal death and impairment of neurological function. Herein, atorvastatin (ATO)-encapsulated super-small nitric oxide (NO)-donor micelles (M-NO@A) based on hyper-branched polyzwitterion are developed to reverse brain injury status and reduce infarct size. M-NO@A upon super-small volume can significantly accumulate in the ischemic region, thereby inhibiting the adhesion of inflammatory cells' to BBB by NO decreasing the expression of intracellular cell adhesion molecule-1 (ICAM-1) on BBB. Additionally, the introduction of NO is adequate to suppress inflammation amplification, in a combination with ATO-mediated oxidative stress reduction to maintain the brain's health synergistically. Meanwhile, significant reduction in cerebral infarct area and marked improvement in neurological function are clearly visualized in transient middle cerebral artery occlusion/reperfusion (tMCAO/R) models treated with M-NO@A. Consequently, these micelles provide a multifaceted strategy for drug delivery to damaged brains, thereby achieving efficient treatment of brain diseases. STATEMENT OF SIGNIFICANCE: The designed atorvastatin (ATO)-encapsulated super-small nitric oxide (NO)-donor micelles (M-NO@A) utilize their ultra-small size and carboxybetaine (CB) functionalization to facilitate efficient blood-brain barrier (BBB) penetration and subsequent brain accumulation. This formulation effectively inhibits inflammatory cell adhesion to the BBB through nitric oxide (NO)-mediated downregulation of intercellular adhesion molecule-1 (ICAM-1) expression. Furthermore, the incorporated NO effectively suppresses inflammatory amplification, while ATO-mediated oxidative stress reduction synergistically preserves brain homeostasis. In transient middle cerebral artery occlusion/reperfusion (tMCAO/R) models, M-NO@A treatment demonstrated significant reductions in cerebral infarct volume and substantial improvements in neurological function. Collectively, these nanomicelles represent a multifaceted therapeutic strategy for targeted drug delivery to the injured brain, offering an effective approach for treating cerebrovascular disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesReactive Oxygen SpeciesInflammationIschemic StrokeNitric Oxide DonorsFree Radical ScavengersAnimalsAtorvastatinMaleBlood-Brain BarrierMiceNitric OxideOxidative Stress

Stichwörter der Autor:innen

Anti-inflammationIschemic strokeMicroglia polarizationNeuroprotectionOxidative stress

Substanzen

MicellesReactive Oxygen SpeciesAtorvastatinNitric Oxide DonorsNitric OxideFree Radical Scavengers

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China.
  • Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: hlqian@cpu.edu.cn.
  • Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: zhaobb_0628@163.com.
  • Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: w.chen@cpu.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • China Pharmaceutical University
  • National Natural Science Foundation of China

Zitieren

APA

Wang, K., Ao, Y., Xiao, Y., Wang, Y., Liang, X., Zhao, M., Zhang, D., Zhong, Y., Qian, H., Zhao, B., & Chen, W. (2025). Super-small zwitterionic nitric oxide-donor micelles efficiently scavenge ROS and alleviate inflammation for combined ischemic stroke therapy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.08.013

Vancouver

Wang K, Ao Y, Xiao Y, Wang Y, Liang X, Zhao M, et al. Super-small zwitterionic nitric oxide-donor micelles efficiently scavenge ROS and alleviate inflammation for combined ischemic stroke therapy. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.08.013

BibTeX
@article{Wang2025,
  author = {Wang, Ke and Ao, Yuli and Xiao, Yiqing and Wang, Yi and Liang, Xiaoping and Zhao, Mingxuan and Zhang, Dongyu and Zhong, Yinan and Qian, Hongliang and Zhao, Bingbing and Chen, Wei},
  title = {Super-small zwitterionic nitric oxide-donor micelles efficiently scavenge ROS and alleviate inflammation for combined ischemic stroke therapy},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.08.013}
}
Kostenlos starten →